Ennov

Ennov has established itself as a key software provider in the life sciences compliance and information management sector with its unified, AI-powered platform. The company serves a global client base, offering modular solutions that integrate critical functions like Regulatory Information Management (RIM), Quality Management Systems (QMS), Clinical Trial Management, and Pharmacovigilance. By focusing on reducing complexity and accelerating deployment, Ennov enables pharmaceutical, biotech, and medical device companies to streamline operations and maintain regulatory compliance more effectively. Its business model is based on software licensing and related services, positioning it as a Revenue Generating, private company.

A unified, AI-powered content and information management software platform built on a configurable architecture. It serves as a common foundation for integrated solutions across Regulatory, Quality, Clinical, Pharmacovigilance, and Commercial domains in life sciences, enabling centralized data access and workflow management.

Ennov competes in a crowded market with large, established players like Veeva Systems, IQVIA, and Oracle, as well as many specialized vendors in areas like RIM, QMS, and CTMS. Its key differentiator is its long-standing focus on a unified platform architecture that integrates multiple functional suites, contrasting with the more modular or point-solution approaches of some competitors.